OBJECTIVE: To examine changes in the prevalence of non-medical prescription drug use and DSM-IV non-medical prescription abuse and dependence in the United States between 1991-1992 and 2001-2002. METHOD: Comparison of the prevalence of past-year non-medical prescription drug use and drug use disorders in the total sample and among lifetime non-medical users in two large national surveys conducted 10 years apart. RESULTS: From 1991-1992 to 2001-2002, the prevalence of DSM-IV non-medical prescription drug use increased by 53%, from 1.5% to 2.3% (p<0.001), and the prevalence of drug use disorders increased by 67% from 0.3% to 0.5% (p<0.001). The conditional prevalence of a disorder among users increased numerically from 19.9% to 23.6%, but this increase was not statistically significant (p=0.15). CONCLUSIONS: There have been substantial increases in the prevalence of prescription drug non-medical use and prescription drug use disorders in the United States. Given the clinical utility of prescription drugs, urgent action is needed to find approaches that balance the need for access to these medications among those who need them, against their potential for abuse and dependence in subgroups of vulnerable individuals.
OBJECTIVE: To examine changes in the prevalence of non-medical prescription drug use and DSM-IV non-medical prescription abuse and dependence in the United States between 1991-1992 and 2001-2002. METHOD: Comparison of the prevalence of past-year non-medical prescription drug use and drug use disorders in the total sample and among lifetime non-medical users in two large national surveys conducted 10 years apart. RESULTS: From 1991-1992 to 2001-2002, the prevalence of DSM-IV non-medical prescription drug use increased by 53%, from 1.5% to 2.3% (p<0.001), and the prevalence of drug use disorders increased by 67% from 0.3% to 0.5% (p<0.001). The conditional prevalence of a disorder among users increased numerically from 19.9% to 23.6%, but this increase was not statistically significant (p=0.15). CONCLUSIONS: There have been substantial increases in the prevalence of prescription drug non-medical use and prescription drug use disorders in the United States. Given the clinical utility of prescription drugs, urgent action is needed to find approaches that balance the need for access to these medications among those who need them, against their potential for abuse and dependence in subgroups of vulnerable individuals.
Authors: Analucía A Alegría; Deborah S Hasin; Edward V Nunes; Shang-Min Liu; Carrie Davies; Bridget F Grant; Carlos Blanco Journal: J Clin Psychiatry Date: 2010-09 Impact factor: 4.384
Authors: Silvia S Martins; Katherine M Keyes; Carla L Storr; Hong Zhu; Richard A Grucza Journal: J Stud Alcohol Drugs Date: 2010-07 Impact factor: 2.582
Authors: Sean Esteban McCabe; John E Schulenberg; Patrick M O'Malley; Megan E Patrick; Deborah D Kloska Journal: Addiction Date: 2013-10-22 Impact factor: 6.526
Authors: Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet Journal: J Pain Date: 2010-03-24 Impact factor: 5.820
Authors: Bridget A Hearon; Amanda W Calkins; Daniella M Halperin; R Kathryn McHugh; Heather W Murray; Michael W Otto Journal: Am J Drug Alcohol Abuse Date: 2010-11-19 Impact factor: 3.829
Authors: Wilfrid Noel Raby; Kenneth M Carpenter; Jami Rothenberg; Adam C Brooks; Huiping Jiang; Maria Sullivan; Adam Bisaga; Sandra Comer; Edward V Nunes Journal: Am J Addict Date: 2009 Jul-Aug